Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile function in the anesthetized dog

Journal of Urology

Volumn 160, Issue 1, 1998, Pages 242-246

  Carter, Anthony J ^a   Ballard, Stephen A ^a   Naylor, Alasdair M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

3',5' cyclic GMP phosphodiesterase inhibitors; Dog; Impotence; Male; Penile erection

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTOBARBITAL; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOG; DRUG INHIBITION; ENZYME INHIBITION; ERECTILE DYSFUNCTION; HEART RATE; MALE; NERVE STIMULATION; NONHUMAN; PELVIC NERVE; PENIS ERECTION; PRIORITY JOURNAL;

EID: 0032323503     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63097-0     Document Type: Article

References (21)

1. Jeffcoate, W. J.: The investigation of impotence. Br. J. Urol., 68: 449, 1991.
2. NIH Consensus Development Panel on Impotence.: Impotence. Int. J. Impotence Res., 5: 181, 1993.
3. Montorsi, F., Guazzoni, G., Rigatti, P. and Pozza, G.: Pharmacological management of erectile dysfunction. Drugs, 50: 465, 1995.
4. Montague D. K., Barada J. H., Belker A. M., Levine L. A., Nadig P. W., Roehrborn C. G., Sharlip I. D. and Bennett A. H.: Clinical guidelines on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J. Urol., 156: 2007, 1996.
5. Burnett A. L.: Role of nitric acid in the physiology of erection. Biol. Reprod., 52: 485, 1995.
6. Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Osterloh, I. H. and Gingell, C.: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impotence Res., 8: 47, 1996.
7. Boolell, M., Gepi-Attee, S., Gingell, J. C. and Allen, M. J.: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Urol., 78: 257, 1996.
8. Azadzoi, K. M. and De Tejada, I. S.: Hypercholesterolemia impairs endothelium dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol., 146: 238, 1991.
9. G-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol. Scand., 143: 299, 1991.
10. Meyer, M. F., Jahier, A., Krah, H., Staubesand, J., Becker, A. J., Kircher, M., Mayer, B., Jonus, U., Forssmann, W. G. and Stief, C. G.: Intracavernous application of SIN-I in rabbit and man: Functional and toxicological results. Ann. Urol., 27: 179, 1993.
11. Trigo-Rocha, F., Aronson, W. J., Hohenfellner, M., Ignarro, L . J., Rajfer, J. and Lue, T. F.: Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am. J. Physiol., 264: H419, 1993.
12. Trigo-Rocha, F., Hsu, G. L., Donatucci, C. F. and Lue, T. F.: The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection. J. Urol., 149: 872, 1993
13. Wang, R., Higuera, T. R., Sikka, S. C., Minkes, R. K., Bellan, J. A., Kadowitz, P. J., Domer, F. R. and Hellstrom, W. J.: Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside. Urol. Res., 21: 75, 1993.
14. Trigo-Rocha, F., Hsu, G-L., Donatucci, C. F., Martinez-Pineiro, L., Lue, T. F. and Tanagho, E. A.: Intracellular mechanism of penile erection in monkeys. Neurourol. Urodyn., 13: 71, 1994.
15. Ignarro, L. J., Bush, P. A., Buga, G. M., Wood, K. S., Fukuto, J. M. and Rajfer, J.: Nitric oxide and cyclic GMP formation upon field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun., 170: 843, 1990.
16. Bush, P. A., Aronson, W. J. Buga, G. M., Rajfer, J. and Ignarro, L. J.: Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J. Urol., 147: 1650, 1992.
17. Knipsel, H. H., Goessl, C. and Beckman, R.: Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urol. Res., 20: 253, 1992.
18. Juenemann, K-P., Lue, T. F., Luo, J-A., Jadallah, S. A., Nunes, L. L. and Tanagho, E. A.: The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study. J. Urol., 138: 871, 1987.
19. Takahashi, Y., Ishii, N., Lue, T. F. and Tanagho, E. A.: Effects of adenosine on canine penile erection. J. Urol., 148: 1323, 1992.
20. Ballard, S. A., Burslem, F. M. F., Gingell, C. J. C., Price, M. E., Tang, K., Turner, L. A. and Naylor, A. M.: In vitro profile of UK-92,480, an inhibitor of cyclic GMP-specific phosphodiesterase 5 for the treatment of male erectile dysfunction. J. Urol., 155: 676A, 1996 [abstract].
21. Carter, A. J., Ballard, S. A. and Naylor, A. M.: Effects of sildenafil on intracavernosal pressure rises induced by injection of sodium nitroprusside into the corpus cavernosum in the anaesthetised dog. Presented at the second meeting of the European Society for Impotence Research, 1997.